Cargando…

Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2

The coexistence of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) autoantibodies in the same individual is surprisingly often observed. We herein report the first case of LGI1 encephalitis followed by Isaacs syndrome in which LGI1 and CASPR2 antibodies in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Aki, Sugaya, Keizo, Hara, Makoto, Kawazoe, Tomoya, Tobisawa, Shinsuke, Nakajima, Hideto, Takahashi, Kazushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292997/
https://www.ncbi.nlm.nih.gov/pubmed/36223927
http://dx.doi.org/10.2169/internalmedicine.9670-22
_version_ 1785062923928862720
author Murayama, Aki
Sugaya, Keizo
Hara, Makoto
Kawazoe, Tomoya
Tobisawa, Shinsuke
Nakajima, Hideto
Takahashi, Kazushi
author_facet Murayama, Aki
Sugaya, Keizo
Hara, Makoto
Kawazoe, Tomoya
Tobisawa, Shinsuke
Nakajima, Hideto
Takahashi, Kazushi
author_sort Murayama, Aki
collection PubMed
description The coexistence of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) autoantibodies in the same individual is surprisingly often observed. We herein report the first case of LGI1 encephalitis followed by Isaacs syndrome in which LGI1 and CASPR2 antibodies in the serum and cerebrospinal fluid (CSF) were measured during the entire disease course. After the resolution of limbic encephalitis, LGI1 antibodies disappeared from the CSF simultaneously with the appearance of CASPR2 antibodies in the serum. The alternating presence of these pathogenic autoantibodies along with the clinical and phenotypic alternations suggested that LGI1 encephalitis was associated with CASPR2 autoantibody production in the peripheral tissue, leading to CASPR2-associated Isaacs syndrome.
format Online
Article
Text
id pubmed-10292997
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-102929972023-06-28 Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2 Murayama, Aki Sugaya, Keizo Hara, Makoto Kawazoe, Tomoya Tobisawa, Shinsuke Nakajima, Hideto Takahashi, Kazushi Intern Med Case Report The coexistence of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) autoantibodies in the same individual is surprisingly often observed. We herein report the first case of LGI1 encephalitis followed by Isaacs syndrome in which LGI1 and CASPR2 antibodies in the serum and cerebrospinal fluid (CSF) were measured during the entire disease course. After the resolution of limbic encephalitis, LGI1 antibodies disappeared from the CSF simultaneously with the appearance of CASPR2 antibodies in the serum. The alternating presence of these pathogenic autoantibodies along with the clinical and phenotypic alternations suggested that LGI1 encephalitis was associated with CASPR2 autoantibody production in the peripheral tissue, leading to CASPR2-associated Isaacs syndrome. The Japanese Society of Internal Medicine 2022-10-12 2023-06-01 /pmc/articles/PMC10292997/ /pubmed/36223927 http://dx.doi.org/10.2169/internalmedicine.9670-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Murayama, Aki
Sugaya, Keizo
Hara, Makoto
Kawazoe, Tomoya
Tobisawa, Shinsuke
Nakajima, Hideto
Takahashi, Kazushi
Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
title Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
title_full Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
title_fullStr Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
title_full_unstemmed Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
title_short Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
title_sort leucine-rich glioma-inactivated 1 encephalitis followed by isaacs syndrome: alternating presence of pathogenic autoantibodies to leucine-rich glioma-inactivated 1 and contactin-associated protein-like 2
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292997/
https://www.ncbi.nlm.nih.gov/pubmed/36223927
http://dx.doi.org/10.2169/internalmedicine.9670-22
work_keys_str_mv AT murayamaaki leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2
AT sugayakeizo leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2
AT haramakoto leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2
AT kawazoetomoya leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2
AT tobisawashinsuke leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2
AT nakajimahideto leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2
AT takahashikazushi leucinerichgliomainactivated1encephalitisfollowedbyisaacssyndromealternatingpresenceofpathogenicautoantibodiestoleucinerichgliomainactivated1andcontactinassociatedproteinlike2